Treatment of Skin Infections in Diabetic Patients

Classification and Treatment

For diabetic skin infections, antibiotics should be selected based on infection severity, with clindamycin or dicloxacillin for mild infections, and broader coverage with fluoroquinolones plus clindamycin or piperacillin-tazobactam for moderate to severe infections, as recommended by the Infectious Diseases Society of America 1, 2
Diabetic skin infections should be classified as mild, moderate, or severe to guide appropriate antibiotic selection, according to the Infectious Diseases Society of America 3, 2
Mild infections involve only the skin and subcutaneous tissue with minimal inflammation, as defined by the Infectious Diseases Society of America 4, 2
Moderate infections involve deeper tissues or more extensive cellulitis, as classified by the Infectious Diseases Society of America 4, 2
Severe infections are associated with systemic toxicity or metabolic instability, as defined by the Infectious Diseases Society of America 4, 2

First-line options for mild infections include dicloxacillin, clindamycin, cephalexin, and amoxicillin-clavulanate, as recommended by the Infectious Diseases Society of America 1, 2
For moderate infections, recommended options include levofloxacin or ciprofloxacin with clindamycin, cefoxitin, ampicillin-sulbactam, ertapenem, and moxifloxacin, according to the Infectious Diseases Society of America 1, 2
For severe infections, first-line options include vancomycin plus piperacillin-tazobactam, vancomycin plus ceftazidime, cefepime, or a carbapenem, and imipenem-cilastatin, as recommended by the Infectious Diseases Society of America 1, 2

If MRSA is suspected or confirmed, add linezolid, daptomycin, or vancomycin to the treatment regimen, as recommended by the Infectious Diseases Society of America 1, 2, 5
Pseudomonas aeruginosa is an uncommon pathogen in diabetic foot infections, but consider empiric Pseudomonas coverage in patients with macerated wounds, previous isolation of Pseudomonas, or moderate or severe infection in patients from Asia or North Africa, according to the Infectious Diseases Society of America 2, 5

Most skin and soft tissue infections respond well to 1-2 weeks of antibiotic therapy, but extend treatment up to 3-4 weeks if the infection is extensive or resolving slower than expected, as recommended by the Infectious Diseases Society of America 3, 2
Re-evaluate if evidence of infection has not resolved after 4 weeks of appropriate therapy, and monitor clinical response daily for inpatients and every 2-5 days initially for outpatients, according to the Infectious Diseases Society of America 3, 2

Do not treat clinically uninfected foot ulcers with antibiotics, as this promotes resistance without clinical benefit, as warned by the Infectious Diseases Society of America 3, 4
Avoid continuing antibiotics until wound healing, as there is no evidence supporting this practice, according to the Infectious Diseases Society of America 2
Avoid underdosing antibiotics, which may lead to treatment failure and development of resistance, as cautioned by the Infectious Diseases Society of America 3
Antibiotic therapy alone is insufficient; appropriate wound care, debridement, and pressure off-loading are crucial components of treatment, as emphasized by the Infectious Diseases Society of America 4, 2